HomeInsights52 Week High Stocks

Aurobindo Pharma Ltd 52 Week High

Aurobindo Pharma Ltd 52 Week High

stocks purchased

₹ 3.9 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

31.6 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

YEARHIGH

₹ 1592.55

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week HIGH of Aurobindo Pharma Ltd is ₹ 1592 as of 20 Dec 24 .

Company Fundamentals for Aurobindo Pharma Ltd

No data available

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20241240.7
19 Dec 20241255.4
18 Dec 20241247.85
17 Dec 20241213.45
16 Dec 20241245
13 Dec 20241207.95
12 Dec 20241215.15
11 Dec 20241225.7
10 Dec 20241238.05
09 Dec 20241239.4

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Aurobindo Pharma Ltd News Hub

News

Auro Pharma gets UK MHRA nod for cancer drug

Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (4...

Read more

21 Dec 2024 15:20

News

Auro Pharma's Telangana unit gets 2 USFDA observations

The United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufactu...

Read more

18 Dec 2024 11:17

News

Apitoria Pharma's Unit V completes USFDA inspection

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) in...

Read more

17 Dec 2024 19:55

News

Aurobindo Pharma arm receives positive opinion from EMA for Zefylti

The CHMP has recommended the granting of marketing authorization for Zefylti, which is int...

Read more

14 Dec 2024 16:18

News

Aurobindo Pharma Ltd drops for fifth straight session

Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1...

Read more

13 Dec 2024 13:35

News

CuraTeQ Biologics received recommendation of a marketing authorisation for Zefylti

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma,  announced that the Comm...

Read more

13 Dec 2024 18:31

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Aurobindo Pharma Ltd

What is the significance of Aurobindo Pharma Ltd reaching its 52-week high?

Aurobindo Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Aurobindo Pharma Ltd 52-week high?

Investors monitor Aurobindo Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Aurobindo Pharma Ltd a good buy when it hits its 52-week high?

Whether Aurobindo Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Aurobindo Pharma Ltd fundamentals.

What should I consider before investing in Aurobindo Pharma Ltd at its 52-week high?

Before investing in Aurobindo Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Aurobindo Pharma Ltd stock price continue to rise after reaching its 52-week high?

Aurobindo Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions